Renalytix Plc
RNLXY
$0.225
$0.00853.93%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 36.02% | 26.64% | 5.47% | 6.35% | 7.03% |
| Total Depreciation and Amortization | -42.90% | -14.29% | -47.04% | 161.69% | 15.00% |
| Total Amortization of Deferred Charges | -37.50% | -50.00% | 100.00% | 789.66% | -20.00% |
| Total Other Non-Cash Items | 30.19% | 23.65% | 181.93% | -10.00% | 68.25% |
| Change in Net Operating Assets | -183.78% | -161.38% | 207.41% | -67.15% | 67.31% |
| Cash from Operations | 32.98% | 11.66% | 21.96% | 1.86% | 14.30% |
| Capital Expenditure | -- | -- | -104.84% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 196.72% | 196.97% | 100.00% |
| Cash from Investing | -- | -- | 5,500.00% | 175.29% | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 81.13% | 47.80% | 51.62% | -100.13% | -200.00% |
| Issuance of Common Stock | -33.23% | -33.72% | -81.88% | 127.93% | 124.13% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -71.79% | -73.16% | 39.59% | 37.75% | 37.75% |
| Cash from Financing | -30.29% | -37.45% | -94.35% | -31.42% | -33.56% |
| Foreign Exchange rate Adjustments | -95.84% | -113.07% | 111.63% | 151.91% | 163.56% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 24.30% | -20.12% | -4,352.70% | -13.16% | 26.35% |
